| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | rofecoxib | FAERS: 3 | US FAERS | |
| 2 | Buprenorphine | FAERS: 1 | US FAERS | |
| 3 | Norgestrel | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Tacrolimus | FAERS: 1 | US FAERS | |
| 5 | bivalirudin | FAERS: 1 | US FAERS | |
| 6 | elbasvir-grazoprevir drug combination | FAERS: 1 | US FAERS | |
| 7 | gadodiamide | FAERS: 1 | US FAERS | |
| 8 | reviparin | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.